Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|November 21, 2007
Unlocking diamond's potential as an electronic materialR S Balmer, I Friel, S M Woollard, et al.Journal of Medicinal Chemistry|October 28, 2005
2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 2. Synthesis, chirality, and pharmacokineticsAlan D Borthwick, Dave E Davies, Anne M Exall, et al.American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|March 31, 2007
Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the ratGerald P McCafferty, Mark A Pullen, Charlene Wu, et al.Bioorganic & Medicinal Chemistry Letters|May 7, 2002
Identification of potent and selective oxytocin antagonists. Part 2: further investigation of benzofuran derivativesPaul G Wyatt, Michael J Allen, Josie Chilcott, et al.Toxicology and Applied Pharmacology|April 23, 2013
Minipig and beagle animal model genomes aid species selection in pharmaceutical discovery and developmentJessica J Vamathevan, Matthew D Hall, Samiul Hasan, et al.Journal of Medicinal Chemistry|July 11, 2006
2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 3. Synthesis, pharmacokinetics, and in vivo potencyAlan D Borthwick, Dave E Davies, Anne M Exall, et al.Journal of Physics. Condensed Matter : an Institute of Physics Journal|August 12, 2011
Chemical vapour deposition synthetic diamond: materials, technology and applicationsR S Balmer, J R Brandon, S L Clewes, et al.Journal of Medicinal Chemistry|January 14, 2012
Pyridyl-2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists: synthesis, pharmacokinetics, and in vivo potencyAlan D Borthwick, John Liddle, Dave E Davies, et al.Bioorganic & Medicinal Chemistry Letters|February 16, 2010
The identification of a selective dopamine D2 partial agonist, D3 antagonist displaying high levels of brain exposureIan P Holmes, Richard J Blunt, Olivier E Lorthioir, et al.Journal of Medicinal Chemistry|December 7, 2010
Integration of lead optimization with crystallography for a membrane-bound ion channel target: discovery of a new class of AMPA receptor positive allosteric modulatorsSimon E Ward, Mark Harries, Laura Aldegheri, et al.Pageof 7